(Q38441123)

English

Substitution of cyclophosphamide in the modified BuCy regimen with fludarabine is associated with increased incidence of severe pneumonia: a prospective, randomized study.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Substitution of cyclophosphamide in the modified BuCy regimen with fludarabine is associated with increased incidence of severe pneumonia: a prospective, randomized study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Dai-hong Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Lan-ping Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Xiao-hui Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Yu Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Chen-hua Yan

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Jing-zhi Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Feng-rong Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Yu-qian Sun

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Yu Ji

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Yuan-yuan Zhang

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Kai-yan Liu

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

17 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

98

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

708-715

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242024%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Serum TNFalpha levels in patients with acute graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1460-3

21 January 2018

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1460-3

21 January 2018

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1460-3

21 January 2018

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1460-3

21 January 2018

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1460-3

21 January 2018

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1460-3

21 January 2018

Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1460-3

21 January 2018

New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1460-3

21 January 2018

Cytotoxic drug-induced pulmonary disease: update 1980.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1460-3

21 January 2018

Definitions of cytomegalovirus infection and disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1460-3

21 January 2018

Fludarabine-based reduced intensity conditioning transplants have a higher incidence of cytomegalovirus reactivation compared with myeloablative transplants

1 reference

https://api.crossref.org/works/10.1007%2FS12185-013-1460-3

21 January 2018

Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24242024

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24242024

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade

1 reference

https://pubmed.ncbi.nlm.nih.gov/24242024

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24242024

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24242024

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38441123&oldid=2201711594"